Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20071
20083
20091
20101
20111
20122
20132
20144
20151
20191
20211
20223
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting6
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AOP Orphan Pharmaceuticals AG3
Alliance for Clinical Trials in Oncology2
CTI BioPharma2
Incyte Corporation2
Memorial Sloan Kettering Cancer Center2
Novartis Pharmaceuticals2
PharmaEssentia Japan K.K.2
Protagonist Therapeutics, Inc.2
Case Comprehensive Cancer Center1
Consorzio Mario Negri Sud1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera32
Thrombocythemia, Essential17
Myeloproliferative Disorders16
Primary Myelofibrosis15
Blast Crisis10
Burkitt Lymphoma10
Hodgkin Disease10
Immunoblastic Lymphadenopathy10
Immunoglobulin Light-chain Amyloidosis10
Leukemia, Hairy Cell10

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.